Embodiments of the present invention aim to provide a pharmaceutical composition for treating spina bifida. The pharmaceutical composition exhibited significant increases in embryonic development; and more particularly the closure of the spinal neural tube. Besides, the pharmaceutical composition shows higher uptake of linoleic acid in comparison to other diets. Further, the periconceptional intake of said pharmaceutical composition promotes the embryonic development. In accordance with an embodiment of the present invention, a pharmaceutical composition for treating a spina bifida wherein said pharmaceutical composition is an extract from Nigella sativa. In accordance with an embodiment of the present invention wherein said extract comprising linoleic acid.
For any inquiries, kindly contact:
Lee Ching Shya
UMCIC Business Officer University of Malaya